Background: The Transmission Reduction Intervention Project (TRIP) is a network-based intervention that aims at decreasing human immunodeficiency virus type 1 (HIV-1) spread. We herein explore associations between transmission links as estimated by phylogenetic analyses, and social network-based ties among persons who inject drugs (PWID) recruited in TRIP. Methods: Phylogenetic trees were inferred from HIV-1 sequences of TRIP participants. Highly supported phylogenetic clusters (transmission clusters) were those fulfilling 3 different phylogenetic confidence criteria. Social network-based ties (injecting or sexual partners, same venue engagement) were determined based on personal interviews, recruitment links, and field observation. Results: TRIP recruited 356 individuals (90.2% PWID) including HIV-negative controls; recently HIV-infected seeds; long-term HIV-infected seeds; and their social network members. Of the 150 HIV-infected participants, 118 (78.7%) were phylogenetically analyzed. Phylogenetic analyses suggested the existence of 13 transmission clusters with 32 sequences. Seven of these clusters included 14 individuals (14/32 [43.8%]) who also had social ties with at least 1 member of their cluster. This proportion was significantly higher than what was expected by chance. Conclusions: Molecular methods can identify HIV-infected people socially linked with another person in about half of the phylogenetic clusters. This could help public health efforts to locate individuals in networks with high transmission rates.
Background: The Transmission Reduction Intervention Project (TRIP) is a network-based intervention that aims at decreasing human immunodeficiency virus type 1 (HIV-1) spread. We herein explore associations between transmission links as estimated by phylogenetic analyses, and social network-based ties among persons who inject drugs (PWID) recruited in TRIP. Methods: Phylogenetic trees were inferred from HIV-1 sequences of TRIP participants. Highly supported phylogenetic clusters (transmission clusters) were those fulfilling 3 different phylogenetic confidence criteria. Social network-based ties (injecting or sexual partners, same venue engagement) were determined based on personal interviews, recruitment links, and field observation. Results: TRIP recruited 356 individuals (90.2% PWID) including HIV-negative controls; recently HIV-infected seeds; long-term HIV-infected seeds; and their social network members. Of the 150 HIV-infectedparticipants, 118 (78.7%) were phylogenetically analyzed. Phylogenetic analyses suggested the existence of 13 transmission clusters with 32 sequences. Seven of these clusters included 14 individuals (14/32 [43.8%]) who also had social ties with at least 1 member of their cluster. This proportion was significantly higher than what was expected by chance. Conclusions: Molecular methods can identify HIV-infected people socially linked with another person in about half of the phylogenetic clusters. This could help public health efforts to locate individuals in networks with high transmission rates.
Authors: S R Friedman; A Neaigus; B Jose; R Curtis; M Goldstein; G Ildefonso; R B Rothenberg; D C Des Jarlais Journal: Am J Public Health Date: 1997-08 Impact factor: 9.308
Authors: Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton Journal: N Engl J Med Date: 2015-07-20 Impact factor: 91.245
Authors: Keren Middelkoop; Cecilia Rademeyer; Ben B Brown; Tamaryn J Cashmore; Jinny C Marais; Andrew P Scheibe; Gama P Bandawe; Landon Myer; Jonathan D Fuchs; Carolyn Williamson; Linda-Gail Bekker Journal: J Acquir Immune Defic Syndr Date: 2014-04-01 Impact factor: 3.731
Authors: Fredrik Ronquist; Maxim Teslenko; Paul van der Mark; Daniel L Ayres; Aaron Darling; Sebastian Höhna; Bret Larget; Liang Liu; Marc A Suchard; John P Huelsenbeck Journal: Syst Biol Date: 2012-02-22 Impact factor: 15.683
Authors: D Paraskevis; G K Nikolopoulos; G Magiorkinis; I Hodges-Mameletzis; A Hatzakis Journal: Infect Genet Evol Date: 2016-06-14 Impact factor: 3.342
Authors: Gkikas Magiorkinis; Timokratis Karamitros; Tetyana I Vasylyeva; Leslie D Williams; Jean L Mbisa; Angelos Hatzakis; Dimitrios Paraskevis; Samuel R Friedman Journal: Am J Epidemiol Date: 2018-12-01 Impact factor: 4.897
Authors: Jing-Siang Jhang; Hanoch Livneh; Shu-Yi Yang; Hui-Ju Huang; Michael W Y Chan; Ming-Chi Lu; Chia-Chou Yeh; Tzung-Yi Tsai Journal: BMJ Open Diabetes Res Care Date: 2020-03
Authors: Franziska Hufsky; Ana Abecasis; Patricia Agudelo-Romero; Magda Bletsa; Katherine Brown; Claudia Claus; Stefanie Deinhardt-Emmer; Li Deng; Caroline C Friedel; María Inés Gismondi; Evangelia Georgia Kostaki; Denise Kühnert; Urmila Kulkarni-Kale; Karin J Metzner; Irmtraud M Meyer; Laura Miozzi; Luca Nishimura; Sofia Paraskevopoulou; Alba Pérez-Cataluña; Janina Rahlff; Emma Thomson; Charlotte Tumescheit; Lia van der Hoek; Lore Van Espen; Anne-Mieke Vandamme; Maryam Zaheri; Neta Zuckerman; Manja Marz Journal: Viruses Date: 2022-07-12 Impact factor: 5.818
Authors: Vlad Novitsky; Jon A Steingrimsson; Mark Howison; Fizza S Gillani; Yuanning Li; Akarsh Manne; John Fulton; Matthew Spence; Zoanne Parillo; Theodore Marak; Philip A Chan; Thomas Bertrand; Utpala Bandy; Nicole Alexander-Scott; Casey W Dunn; Joseph Hogan; Rami Kantor Journal: Sci Rep Date: 2020-10-29 Impact factor: 4.379